The science driven BioPark at the heart of Europe.
Brussels South Charleroi BioPark is a premier biotechnology hub located in Charleroi, Hainaut, at the heart of Europe. Originally founded by the Université Libre de Bruxelles (ULB) in 1999, Brussels South Charleroi BioPark cultivates a dynamic ecosystem where scientific rigor, clinical application, and business acumen converge. This unique environment fosters drug research, development, and advancements across the broader life sciences domain. With world-class facilities, Brussels South Charleroi BioPark offers an ideal setting for groundbreaking innovations.
Brussels South Charleroi BioPark is dedicated to supporting the growth of companies, from pioneering startups to established global leaders in life sciences. The BioPark delivers essential services at every stage of a company's journey, from initial inception to providing comprehensive 'soft-landing' support for international companies seeking a strategic base in Europe. Strategically located in Charleroi, with excellent proximity to Brussels and international transportation networks, the BioPark is home to a vibrant community of over 3300 highly skilled professionals from more than 60 countries, encompassing 106 life sciences companies and three world-class research institutes.
Companies within Brussels South Charleroi BioPark benefit from access to one of Europe’s most sophisticated financial ecosystems, offering a comprehensive range of capital resources—from seed funding, specialist venture capitalists, and private equity to access to public equity markets. This is complemented by non-dilutive funding opportunities through national and regional grants. The primary address of Brussels South Charleroi BioPark is Rue Auguste Piccard 48, Charleroi, Hainaut 6041, BE. We invite the management of Brussels South Charleroi BioPark to enhance your company’s presence by creating a customized and exclusive company showcase and product listing on our platform.
Compare Brussels South Charleroi BioPark with 3 companies in Biotechnology
| Comparison Field |
Brussels South Charleroi...Main Company |
Precede BiosciencesView Profile |
Engimmune Therapeuti...View Profile |
second scightView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2021 | 2021 | 2024 |
|
Company Size
|
— | 11-50 | 11-50 | 1 employee |
|
City
|
Charleroi, Hainaut | Allschwil, Basel-Country | ||
|
Country
|
Switzerland | |||
|
Skills & Keywords
Comparing with main company
|
27 Total Skills
Biotechnology
Life Sciences
Drug Development
Venture Capital
Research and Development
Biotech Incubator
Pharmaceuticals
oncology
medical device
funding
biotech real estate
immunology
orthopaedics
incubator
cell therapy
ATMP
talents
next generation sequencing
diagnostics
drug development
entrepreneurship
gene therapy
central nervous system
biotechnology
molecular biology
Immunotherapy
private equity
|
11 Total
11 Unique
Unique Skills:
ai
artificial intelligence
biology
cancer
genomic liquid biopsy
genomic medicine
+5
|
2 Total
2 Unique
Unique Skills:
machine learning
T cell therapy
|
16 Total
16 Unique
Unique Skills:
bioinformatics
biostatistics
business intelligence
data analytics
data visualization
due diligence
+10
|
Other organizations in the same industry
This company is also known as